Search research articles
Contact Us
Filters
Showing results (521-530 of 585) with videos related to
Page
of 59
Sort By:
Breast Cancer Research and Treatment
|
November 24, 2024
Real-world quality-of-life of patients with HR+/HER2- advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS
Gabrielle B Rocque, Joanne L Blum, Yan Ji, et al.
Hepatology International
|
August 24, 2022
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy
Kang Wang, Yanjun Xiang, Jiangpeng Yan, et al.
Medicine
|
November 25, 2020
Clinical effect of catgut implantation at acupoints for the treatment of simple obesity: A multicentre randomized controlled trial
Xia Chen, Wei Huang, Dan Wei, et al.
Current Neurovascular Research
|
November 28, 2022
Lesion Location Predicts Early Neurological Deterioration in Single Subcortical Infarction
Ke Zhang, Hongbing Liu, Ce Zong, et al.
Mucosal Immunology
|
August 5, 2021
Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity
Jinxin Qiu, Jingjing Zhang, Yan Ji, et al.
Cancer Science
|
July 4, 2020
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer
Yoon-Sim Yap, Joanne Chiu, Yoshinori Ito, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 25, 2015
Exome sequencing reveals novel SPG11 mutation in hereditary spastic paraplegia with complicated phenotypes
Yu-sheng Li, Cheng-yuan Mao, Chang-he Shi, et al.
Sleep & Breathing = Schlaf & Atmung
|
June 5, 2016
Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease
Zi-Jiao Yang, Jing Wei, Cheng-Jie Mao, et al.
JAMA Oncology
|
September 25, 2025
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial
Fatima Cardoso, William Jacot, Sherko Kuemmel, et al.
Thrombosis and Haemostasis
|
April 24, 2026
Plasminogen Activator Inhibitor-1 Controls Mitochondrial Oxidative Stress in Vascular Smooth Muscle Cells and Coronary Arteries
Alex Schoenherr, Yan Ji, Hekmat Khoukaz, et al.
Page
of 59
Search research articles
Search
Showing results (521-530 of 585) with videos related to
Sort By:
Page
of 59
Breast Cancer Research and Treatment
|
November 24, 2024
Real-world quality-of-life of patients with HR+/HER2- advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS
Gabrielle B Rocque, Joanne L Blum, Yan Ji, et al.
Hepatology International
|
August 24, 2022
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy
Kang Wang, Yanjun Xiang, Jiangpeng Yan, et al.
Medicine
|
November 25, 2020
Clinical effect of catgut implantation at acupoints for the treatment of simple obesity: A multicentre randomized controlled trial
Xia Chen, Wei Huang, Dan Wei, et al.
Current Neurovascular Research
|
November 28, 2022
Lesion Location Predicts Early Neurological Deterioration in Single Subcortical Infarction
Ke Zhang, Hongbing Liu, Ce Zong, et al.
Mucosal Immunology
|
August 5, 2021
Tissue signals imprint Aiolos expression in ILC2s to modulate type 2 immunity
Jinxin Qiu, Jingjing Zhang, Yan Ji, et al.
Cancer Science
|
July 4, 2020
Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer
Yoon-Sim Yap, Joanne Chiu, Yoshinori Ito, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
May 25, 2015
Exome sequencing reveals novel SPG11 mutation in hereditary spastic paraplegia with complicated phenotypes
Yu-sheng Li, Cheng-yuan Mao, Chang-he Shi, et al.
Sleep & Breathing = Schlaf & Atmung
|
June 5, 2016
Retinal nerve fiber layer thinning: a window into rapid eye movement sleep behavior disorders in Parkinson's disease
Zi-Jiao Yang, Jing Wei, Cheng-Jie Mao, et al.
JAMA Oncology
|
September 25, 2025
600- vs 400-mg First-Line Ribociclib in Hormone Receptor-Positive/ERBB2-Negative Advanced Breast Cancer: The AMALEE Randomized Clinical Trial
Fatima Cardoso, William Jacot, Sherko Kuemmel, et al.
Thrombosis and Haemostasis
|
April 24, 2026
Plasminogen Activator Inhibitor-1 Controls Mitochondrial Oxidative Stress in Vascular Smooth Muscle Cells and Coronary Arteries
Alex Schoenherr, Yan Ji, Hekmat Khoukaz, et al.
Page
of 59